Health Condition 1: G804- Ataxic cerebral palsy Health Condition 2: G803- Athetoid cerebral palsy Health Condition 3: G809- Cerebral palsy, unspecified Health Condition 4: G808- Other cerebral palsy Health Condition 5: G801- Spastic diplegic cerebral palsy Health Condition 6: G802- Spastic hemiplegic cerebral palsy Health Condition 7: G800- Spastic quadriplegic cerebral palsy
Conditions
Interventions
Intervention1: ORAL MELATONIN: MELATONIN IS A SUBSTANCE NATURALLY PRODUCED IN HUMAN PINEAL GLAND THAT HELPS TO REGULATE OUR SLEEP AND WAKE CYCLE THROUGH ITS ACTION ON SUPRACHISMATIC NUCLEUS IN THE HYP
Sponsors
GIRE POOJA K
Eligibility
Inclusion criteria
Inclusion criteria: ALL THE CHILDREN DAIGNOSED WITH CEREBRAL PALSY AGE 3YRS TO 12 YRS WITH SLEEP PROBLEMS DEFINED BY PRESENCE OF ONE OR MORE OF THE FOLLOWING ; 1.WHO DID NOT FALL ASLEEP AFTER 1HR OF LIGHTS OFF. 2.WAKES UP ONCE OR MORE DURING NIGHT . 3.GETS LESS THAN 6HRS OF SLEEP 4.CHILDREN WHO FAIL BEHAVIORAL MANAGMENT STRATERGIES FOR SLEEP DISTURBANCES.
Exclusion criteria
Exclusion criteria: 1.CHILDREN ALREADY TREATED WITH MELATONIN OR TAKING MELATONIN. 2.CHILDREN HAVING SYMPTOMS AND SIGNS OF OBSTRUCTIVE SLEEP APNEA. 3.KNOW ALLERGY TO MELATONIN. 4.CHILDREN WITH NOCTURNAL SEIZURES. 5.CHILDREN WHOSE PARENTS OR CARETAKERS ARE NOT WILLING TO PARICIPATE IN STUDY
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO IMPROVE TOTAL DURATION OF SLEEP BY 1 HOUR IN MELATONIN GROUP AS COMPARED TO PLACEBO GROUP.Timepoint: 3 MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| TO DECREASE SLEEP LATENCY IN MELATONIN GROUP AS COMPARED TO PLACEBO GROUPTimepoint: 3 MONTHS;TO STUDY SIDEEFFECTS OF MELATONIN IF ANYTimepoint: 3MONTHS | — |
Countries
India
Contacts
Public ContactGIRE POOJA K
GOVERNMENT MEDICAL COLLEGE AND HOSPITAL AURANGABAD
Outcome results
None listed